Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Leoni

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Vaccines|August 28, 2021
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' PredictionGuido Leoni, Anna Morena D'Alise, Fabio Giovanni Tucci, et al.
Vaccines|March 28, 2024
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer VaccineRosa Bartolomeo, Fulvia Troise, Simona Allocca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell ResponsesAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Cell Death and Differentiation|May 5, 2026
The RNA binding protein LIN28A mediates chromatin dynamics during neuronal differentiationSilvia Piscitelli, Emanuela Cascone, Chiara D'Ambrosio, et al.
NPJ Precision Oncology|December 20, 2024
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial CancerElisa De Paolis, Camilla Nero, Elisa Micarelli, et al.
Journal for Immunotherapy of Cancer|November 26, 2021
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletionAnna Morena D'Alise, Guido Leoni, Maria De Lucia, et al.
Nature Communications|June 21, 2019
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockadeAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Science Translational Medicine|August 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejectionAnna Morena D'Alise, Nadia Brasu, Carlo De Intinis, et al.
JAMA Oncology|May 1, 2018
Immune Profiling of Premalignant Lesions in Patients With Lynch SyndromeKyle Chang, Melissa W Taggart, Laura Reyes-Uribe, et al.
Cancer Research|July 22, 2020
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite InstabilityGuido Leoni, Anna Morena D'Alise, Gabriella Cotugno, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Vaccines|August 28, 2021
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' PredictionGuido Leoni, Anna Morena D'Alise, Fabio Giovanni Tucci, et al.
Vaccines|March 28, 2024
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer VaccineRosa Bartolomeo, Fulvia Troise, Simona Allocca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell ResponsesAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Cell Death and Differentiation|May 5, 2026
The RNA binding protein LIN28A mediates chromatin dynamics during neuronal differentiationSilvia Piscitelli, Emanuela Cascone, Chiara D'Ambrosio, et al.
NPJ Precision Oncology|December 20, 2024
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial CancerElisa De Paolis, Camilla Nero, Elisa Micarelli, et al.
Journal for Immunotherapy of Cancer|November 26, 2021
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletionAnna Morena D'Alise, Guido Leoni, Maria De Lucia, et al.
Nature Communications|June 21, 2019
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockadeAnna Morena D'Alise, Guido Leoni, Gabriella Cotugno, et al.
Science Translational Medicine|August 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejectionAnna Morena D'Alise, Nadia Brasu, Carlo De Intinis, et al.
JAMA Oncology|May 1, 2018
Immune Profiling of Premalignant Lesions in Patients With Lynch SyndromeKyle Chang, Melissa W Taggart, Laura Reyes-Uribe, et al.
Cancer Research|July 22, 2020
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite InstabilityGuido Leoni, Anna Morena D'Alise, Gabriella Cotugno, et al.
Pageof 5